Fundraising
Bridge Loan
Short-term financing that helps a startup survive until it closes its next equity round — typically structured as a convertible note that converts into the new round.
A bridge loan is short-term debt financing extended to a startup when it needs capital to reach its next financing milestone. Unlike a priced equity round, a bridge loan is typically fast to execute — often funded within days or weeks — and converts into equity when the company closes its next round.
Bridges are most commonly structured as convertible notes with a discount (usually 10–20%) or as SAFEs. They may or may not include interest (typically 5–8% annually). The term 'bridge' reflects the intent: it bridges the company from where it is to where it needs to be to raise its next proper round.
Existing investors frequently lead bridge rounds to protect their ownership without triggering a new priced round. Bridges can be a lifeline for companies close to a milestone, but they can also become a trap if the company repeatedly bridges without hitting the metrics needed to raise a real round.
In Practice
A Series A startup raised $8M 18 months ago. Revenue is growing but not fast enough to command an A+ Series B price. The CEO negotiates a $1.5M bridge from existing investors, structured as a convertible note with a 20% discount cap. This gives the team 6 months to hit $3M ARR and raise a proper Series B.
Why It Matters
Bridge loans are a critical survival mechanism in venture — when capital markets tighten, the ability to bridge determines whether a company lives or dies. From an investor perspective, bridges are a moment of truth: do you have conviction to put in more money at a difficult moment, or do you let the company struggle? Companies that continuously need bridges without hitting milestones are often signaling deeper product-market fit issues.
VC Beast Take
The phrase 'bridge to nowhere' describes what happens when VCs keep bridging a company that should be shut down. Bridges can be rational — market timing, a key hire needed, a product milestone weeks away. But some investors bridge out of loss aversion rather than conviction, prolonging the inevitable. The best bridges have a clear hypothesis: 'If we hit X metric in Y months, we can raise a proper round.' If there's no clear hypothesis, it's not a bridge, it's a life support system.